
|Articles|January 23, 2018
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
2
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Pharmacists Are Essential Partners in Modern Disease Management and Immunization Efforts
5